(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate
97%
- Product Code: 115999
CAS:
210095-58-2
| Molecular Weight: | 452.89 g./mol | Molecular Formula: | C₂₁H₂₅ClN₂O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed away from light |
Product Description:
This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of medications targeting central nervous system disorders, including anxiety and depression. Its structure allows it to interact with specific neurotransmitter receptors, making it valuable for creating compounds that modulate brain activity. Additionally, it is used in research settings to study receptor binding mechanisms and to develop novel therapeutic agents with improved efficacy and reduced side effects. Its application is also explored in the design of drugs for treating chronic pain and other neurological conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | £12.01 |
+
-
|
| 1.000 | 10-20 days | £30.13 |
+
-
|
| 5.000 | 10-20 days | £101.17 |
+
-
|
| 10.000 | 10-20 days | £164.27 |
+
-
|
(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate
This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of medications targeting central nervous system disorders, including anxiety and depression. Its structure allows it to interact with specific neurotransmitter receptors, making it valuable for creating compounds that modulate brain activity. Additionally, it is used in research settings to study receptor binding mechanisms and to develop novel therapeutic agents with improved efficacy and reduced side effects. Its application is also explored in the design of drugs for treating chronic pain and other neurological conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :